Persistent anti-Dra in two pregnancies

Immunohematology

Volumn 21, Issue 3, 2005, Pages 126-128

  Rahimi Levene, Naomi ^a   Kornberg, Abraham ^b   Siegel, Gabriela ^c   Morozov, Valery ^d   Shinar, Eilat ^e   Asher, Orna ^e   Levene, Cyril ^f   Yahalom, Vered ^g  

^a Blood Bank ^*  (Israel)

^b Hematology Institute

^c High Risk Pregnancy Unit

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

^e Immunohematology Laboratory

^f National Blood Group Reference Laboratory (NBGRL)

^g MAGEN DAVID ADOM   (Israel)

Author keywords

Anti Dra; Titers in pregnancy

Indexed keywords

ANTIBODY; ANTIGEN; DECAY ACCELERATING FACTOR; DRA ANTIBODY; DRA ANTIGEN; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; UNCLASSIFIED DRUG; ALLOANTIBODY; BLOOD GROUP ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP CROMER SYSTEM; BLOOD GROUP SYSTEM; CASE REPORT; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOASSAY; ISRAEL; JEW; PHENOTYPE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; SEROPREVALENCE; BLOOD; IMMUNOLOGY;

ADULT; ANTIGENS, CD55; BLOOD GROUP ANTIGENS; FEMALE; HUMANS; ISOANTIBODIES; PREGNANCY;

EID: 25844464186     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304-16.
2. Levene C, Harel N, Lavie G, Greenberg S, et al. A "new" phenotype confirming a relationship between Cra and Tea. Transfusion 1984;24:13-5.
3. a and a family with the Dr(a-) phenotype in two generations. Transfusion 1987;27:64-5.
4. Daniels GL, Green CA, Mollinson G, Okubo Y, et al. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese. Transfus Med 1998;8:141-7.
5. Dickson AC, Guest C, Jordan M, et al. Case report: anti-Cra in pregnancy. Immunohematology 1995;11:14-7.
6. Sacks DA, Garratty G. Isoimmunization to Cromer antigen in pregnancy. Am J Obstet Gynecol 1989;161:928-9.
7. Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory proteins decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099-3105.
8. Reid ME, Chandrasekaran V, Sausais L, et al. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996;71:48-50.
9. Lublin DM, Thompsen ES, Green AM, et al. Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional and molecular characterization and production of allele-specific transfectants. J Clin Invest 1991;87:1945-52.
10. Daniels G: Human blood groups. 2nd ed. Oxford: Blackwell Science, 2002;444-54.
11. Storry JR, Reid ME. The Cromer blood group system: a review. Immunohematology 2002;18: 95-103.